Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Tau Medical Ltd. (DRTS : NSDQ)

• Company Description    Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. Alpha Tau Medical Ltd., formerly known as Healthcare Capital Corp., is based in JERUSALEM. Number of Employees: 112

• Price / Volume Information    Yesterday's Closing Price: $3.06 Daily Weekly Monthly 20 Day Moving Average: 34,957 shares Shares Outstanding: 84.82 (millions) Market Capitalization: $259.55 (millions) Beta: 0.99 52 Week High: $4.39 52 Week Low: $1.93 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.03% -3.53% 12 Week 19.07% 0.48% Year To Date -1.29% -7.25%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Kiryat HaMada St. 5 - Jerusalem,L3 9777605 ISR ph: 972-3577-4115 fax: - ir@alphatau.com http://www.alphatau.com

• General Corporate Information    Officers Uzi Sofer - Chief Executive Officer; Chairman and Director Amnon Gat - Chief Operations Officer Raphi Levy - Chief Financial Officer Michael Avruch - Director Ruth Alon - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: M0740A108 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 84.82 Most Recent Split Date: (:1) Beta: 0.99 Market Capitalization: $259.55 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.11 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.46 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.82 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -9.09% vs. Previous Quarter: 7.69% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -49.48 12/31/24 - -44.54 ROA 06/30/25 - - 03/31/25 - -36.69 12/31/24 - -33.83 Current Ratio 06/30/25 - - 03/31/25 - 5.81 12/31/24 - 7.40 Quick Ratio 06/30/25 - - 03/31/25 - 5.81 12/31/24 - 7.40 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.80 12/31/24 - 0.89 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.10 12/31/24 - 0.09 Debt-to-Capital 06/30/25 - - 03/31/25 - 8.85 12/31/24 - 8.15

Powered by Zacks Investment Research ©